AMZN
Amazon.com, Inc.
AMZN has the edge over TXRH overall, supported by stronger valuation and stronger modeled upside.
TXRH
Texas Roadhouse, Inc.
TXRH trails on the overall score without a compensating advantage in the available component scores.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
TXRH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Strong |
TXRH's revenue, profitability, cash flow and balance sheet are all currently healthy.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over TXRH in the historical PE scenario, which offers more potential upside but is not a forecast.
TXRH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 25x | $158 | -15% |
| Fair | 28x | $177 | -4.7% |
| Current | 29x | $186 | — |
| Expensive | 34x | $219 | +18% |
Historical ranges are pointers, not guarantees.
TXRH's PE is in its fair range at 29x.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
TXRH Forward outlook
There aren't enough analyst estimates for TXRH to show an outlook.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over TXRH on earnings, with more consistent year-over-year improvement.
TXRH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $6.37 | -2.6% |
| Q2 2026 | $6.26 | -4.4% |
| Q1 2026 | $6.27 | -3.2% |
| Q4 2025 | $6.10 | -5.7% |
| Q3 2025 | $6.54 | +12% |
| Q2 2025 | $6.55 | +19% |
| Q1 2025 | $6.48 | +31% |
| Q4 2024 | $6.47 | +43% |
TXRH earned $6.37 per share over the past year, down 2.6% from the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over TXRH on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over TXRH on profitability, with a higher operating margin.
TXRH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.6B | +9.5% |
| Q2 2026 | $1.7B | +11% |
| Q1 2026 | $1.6B | +13% |
| Q4 2025 | $1.5B | +3.1% |
| Q3 2025 | $1.4B | +13% |
| Q2 2025 | $1.5B | +13% |
| Q1 2025 | $1.4B | +9.6% |
| Q4 2024 | $1.4B | +23% |
TXRH's revenue has grown year over year for 23 quarters in a row: $1.6B last quarter, up 9.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.5% | -0.2 points |
| Q2 2026 | 8.5% | -1.2 points |
| Q1 2026 | 9% | -0.3 points |
| Q4 2025 | 6.5% | -3.1 points |
| Q3 2025 | 6.8% | -1.3 points |
| Q2 2025 | 9.7% | -1 points |
| Q1 2025 | 9.3% | -0.8 points |
| Q4 2024 | 9.6% | +2.5 points |
TXRH's operating margin was 6.5% last quarter, about level with the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
TXRH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $11.1M | -25% |
| Q2 2026 | $81.5M | +128% |
| Q1 2026 | $178.9M | +12% |
| Q4 2025 | $131.3M | +1.2% |
| Q3 2025 | $14.7M | -69% |
| Q2 2025 | $35.7M | -36% |
| Q1 2025 | $160.4M | -3.3% |
| Q4 2024 | $129.7M | +82% |
TXRH has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
TXRH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -135K shares |
| 1 year | -1% | -691K shares |
| 3 years | -1.8% | -1.2M shares |
| 5 years | -6.2% | -4.4M shares |
| Available history | -7.2% | -5.1M shares |
TXRH has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $12.4M |
| Q2 2026 | $43.7M |
| Q1 2026 | $28.2M |
| Q4 2025 | $50M |
| Q3 2025 | $40M |
| Q2 2025 | $10.3M |
| Q1 2025 | $50.2M |
| Q4 2024 | $35.3M |
TXRH spent $134M buying back its own shares over the past year, down 1.1% from the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
TXRH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | -0.2x | Net Cash |
| Q1 2026 | -0.2x | Net Cash |
| Q4 2025 | -0.2x | Net Cash |
| Q3 2025 | -0.2x | Net Cash |
| Q2 2025 | -0.3x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | -0.4x | Net Cash |
TXRH has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
TXRH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.0 | Neutral |
| Stochastic | 47.9 | Neutral |
TXRH's weekly RSI is 54 (neutral) and its Stochastic is 48 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over TXRH on valuation relative to its sector.
TXRH PE vs Consumer Cyclical Sector
| Metric | TXRH | Sector median | Relative |
|---|---|---|---|
| PE | 29x | 18x | 62% above |
| PE % | 58 | 47 | 11 pts above |
TXRH is trading at 29x earnings, a 62% premium to the Consumer Cyclical sector's median of 18x.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN is in an uptrend: it's above all five of its weekly moving averages, and 40% above its 200-week average.
TXRH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $170.5 | 9.1% above |
| 20 week MA | $185.0 | 0.5% above |
| 50 week MA | $178.9 | 4% above |
| 100 week MA | $177.4 | 4.8% above |
| 200 week MA | $156.4 | 19% above |
TXRH is in an uptrend: it's above all five of its weekly moving averages, and 19% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over TXRH on returns for 2026, with the stronger performance.
TXRH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $55.0 | $80.0 | +45% |
| 2021 | $80.0 | $88.8 | +11% |
| 2022 | $88.8 | $96.3 | +8.5% |
| 2023 | $96.3 | $122.2 | +27% |
| 2024 | $122.2 | $181.9 | +49% |
| 2025 | $181.9 | $170.8 | -6.1% |
| 2026 YTD | $170.8 | $186.0 | +8.9% |
TXRH has finished higher in five of the last six years. It's up 8.9% so far in 2026.